Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Jardiance 25 mg thrice-weekly post-hemodialysis dosing

Filter by location:

Jackson, Mississippi1 trial

Empagliflozin in ESKD - A Feasibility Study

University of Mississippi Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.